Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review

Cancer Management and Research
Christopher J McNallyDeclan J McKenna

Abstract

Prediction of prostate cancer in primary care is typically based upon serum total prostate-specific antigen (tPSA) and digital rectal examination results. However, these tests lack sensitivity and specificity, leading to over-diagnosis of disease and unnecessary, invasive biopsies. Therefore, there is a clinical need for diagnostic tests that can differentiate between benign conditions and early-stage malignant disease in the prostate. In this review, we evaluate research papers published from 2009 to 2019 reporting biomarkers that identified or differentiated benign prostatic hyperplasia (BPH) from prostate cancer. Our review identifies hundreds of potential biomarkers in urine, serum, tissue, and semen proposed as useful targets for differentiating between prostate cancer and BPH patients. However, it is still not apparent which of these candidate biomarkers are most useful, and many will not progress beyond the discovery stage unless they are properly validated for clinical practice. We conclude that this validation will come through the use of multivariate panels which can assess the value of biomarker candidates in combination with clinical parameters as part of a risk prediction calculator. Implementation of such a model ...Continue Reading

References

May 9, 1992·BMJ : British Medical Journal·C Chapple
Nov 3, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Zaher K OtrockAbdul Rahman N Bizri
Apr 20, 2006·Journal of the National Cancer Institute·Ian M ThompsonCharles A Coltman
May 19, 2006·Cancer Research·Peter J M HendriksenGuido Jenster
Dec 20, 2008·Journal of Proteome Research·Jennifer C ByrneR William G Watson
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Jun 6, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ettore MeariniVincenzo N Talesa
May 8, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lori J SokollDaniel W Chan
Jun 2, 2010·Oncology Reports·Angelina Di CarloVincenzo Macchia
Oct 27, 2010·British Journal of Biomedical Science·N T El MelegyN A Mohamed
Oct 28, 2010·Current Opinion in HIV and AIDS·Kyle Strimbu, Jorge A Tavel
Feb 26, 2011·Journal of the National Cancer Institute·Andrew J VickersIan M Thompson
Nov 22, 2011·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Gianna PaceM Giuliana Tozzi Ciancarelli
Dec 8, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dennis J O'RourkeBrian C-S Liu
Nov 21, 2012·Nature Reviews. Urology·David D Ørsted, Stig E Bojesen
Mar 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deborah A WilliamsonDavid L Paterson
Sep 26, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mario MenschikowskiGabriele Siegert
Feb 12, 2014·Genetic Testing and Molecular Biomarkers·Wanlong MaMaher Albitar
Mar 25, 2014·Medical Oncology·Ugur UyeturkAdnan Gucuk

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies
enzyme-linked
transmission electron microscopy
glycosylation

Software Mentioned

Google Scholar
MRI

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.